Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Non-revolving loan
Quarterly results
Director departure
|
|
GT Biopharma, Inc. (GTBP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Breen Michael Martin (Executive Chairman/Interim CEO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 200,000 shares
@ $0.287, valued at
$57.4k
|
|
| 08/15/2023 |
4
| Ohri Manu (CFO & Secretary) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 200,000 shares
@ $0.287, valued at
$57.4k
Disposed of 200,000 shares
@ $0.287, valued at
$57.4k
Acquired 200,000 shares
@ $0.287, valued at
$57.4k
|
|
| 05/04/2023 |
3
| CASAMENTO CHARLES J (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Breen Michael Martin (Exec. Chair. and Interim CEO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 278,058 shares
@ $0
Granted 50,000 options to buy
@ $2.48, valued at
$124k
|
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| URBAN ALAN LOUIS (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.48, valued at
$124k
|
|
| 07/19/2022 |
4
| Berk Gregory (Pres. of R&D, CMO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.48, valued at
$124k
|
|
| 07/19/2022 |
4
| Ohri Manu (CFO & Secretary) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 100,000 shares
@ $0
Disposed of 100,000 shares
@ $0
Acquired 100,000 shares
@ $0
Granted 200,000 options to buy
@ $2.48, valued at
$496k
|
|
| 07/19/2022 |
4
| Wendel Bruce (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.48, valued at
$124k
|
|
| 06/14/2022 |
3
| URBAN ALAN LOUIS (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 02/18/2022 |
3
| Ohri Manu (CFO) has filed a Form 3 on GT Biopharma, Inc. |
| 02/14/2022 |
4
| Berk Gregory (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 278,058 shares
@ $0
Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
|
|
| 02/14/2022 |
4
| SHROTRIYA RAJESH C MD (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
|
|
| 02/14/2022 |
4
| Choy Gavin (Acting CFO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 227,500 options to buy
@ $3.05, valued at
$693.9k
|
|
| 02/14/2022 |
3
| Berk Gregory (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 02/14/2022 |
3
| Choy Gavin (Acting CFO) has filed a Form 3 on GT Biopharma, Inc. |
| 02/14/2022 |
3
| SHROTRIYA RAJESH C MD (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 11/12/2021 |
4
| Breen Michael Martin (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 278,058 shares
@ $0
Converted 40,243 shares
@ $3.4, valued at
$136.8k
Converted 9,859 shares
@ $3.4, valued at
$33.5k
Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
Converted 100,000 options to buy
@ $3.4, valued at
$340k
Converted 30,000 options to buy
@ $3.4, valued at
$102k
|
|
| 11/12/2021 |
3
| Breen Michael Martin (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 10/07/2021 |
4
| Wendel Bruce (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Bought 3,268 shares
@ $3.14, valued at
$10.3k
Bought 1,374 shares
@ $8.87, valued at
$12.2k
Bought 441 shares
@ $8.73, valued at
$3.8k
Granted 347,572 shares
@ $0
Granted 50,000 options to buy
@ $6.33, valued at
$316.5k
|
|
| 10/07/2021 |
3
| Wendel Bruce (Director) has filed a Form 3 on GT Biopharma, Inc. |
| 12/23/2020 |
4
| Weldon Steven W (Former Officer and Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Sold 50,000 shares
@ $0.3, valued at
$15k
Sold 50,000 shares
@ $0.33, valued at
$16.5k
Sold 35,722 shares
@ $0.34, valued at
$12.1k
Sold 47,978 shares
@ $0.4, valued at
$19.2k
|
|
| 12/18/2020 |
4
| Weldon Steven W (Former Officer and Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Sold 50,000 shares
@ $0.3, valued at
$15k
Sold 50,000 shares
@ $0.3, valued at
$15k
Sold 50,000 shares
@ $0.31, valued at
$15.5k
Sold 50,000 shares
@ $0.3, valued at
$15k
|
|
| 12/15/2020 |
4
| Weldon Steven W (Former Officer and Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Sold 50,000 shares
@ $0.25, valued at
$12.5k
Sold 50,000 shares
@ $0.26, valued at
$13k
Sold 50,000 shares
@ $0.28, valued at
$14k
Sold 50,000 shares
@ $0.29, valued at
$14.5k
Sold 46,300 shares
@ $0.29, valued at
$13.4k
Sold 50,000 shares
@ $0.3, valued at
$15k
Sold 50,000 shares
@ $0.32, valued at
$16k
|
|
| 06/04/2020 |
4
| Cataldo Tony (CEO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Sold 4,234,320 shares
@ $0.001, valued at
$4.2k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2019 |
4
| Cataldo Tony (CEO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 7,000,000 shares
@ $0 |
|
| 08/16/2019 |
4
| Weldon Steven W (CFO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Granted 4,500,000 shares
@ $0 |
|
| 03/19/2019 |
4
| Urbanski Raymond W. (CEO) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Sold 176,980 shares
@ $0.001, valued at
$177 |
|
| 02/13/2019 |
4
| Cataldo Tony (Director) has filed a Form 4 on GT Biopharma, Inc.|
Txns:
| Sold 800,000 shares
@ $0.001, valued at
$800 |
|
|
|
|